2015
Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China.
Lai YJ, Liu EY, Wang LM, Morano JP, Wang N, Khoshnood K, Zhou L, Cheng SM. Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China. Biomedical And Environmental Sciences 2015, 28: 421-8. PMID: 26177902, DOI: 10.3967/bes2015.059.Peer-Reviewed Original ResearchConceptsRisk factorsMiliary TBTB treatmentHuman immunodeficiency virus (HIV) infection epidemicSignificant mortality risk factorsAntiretroviral therapy administrationEarly TB diagnosisLow CD4 countSmear-negative TBTB treatment initiationTuberculosis-related deathsPulmonary TB patientsTB/HIVProspective cohort studyImmunodeficiency syndrome (AIDS) patientsTime of diagnosisMortality risk factorsPulmonary tuberculosis treatmentRisk of deathNumber of HIVStrong risk factorLogistic regression analysisYears of ageNon-Han ethnicityCD4 count
2005
Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia.
Fry RS, Khoshnood K, Vdovichenko E, Granskaya J, Sazhin V, Shpakovskaya L, Zhemkov V, Zhemkova M, Rowhani-Rahbar A, Funk M, Kozlov A. Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia. The International Journal Of Tuberculosis And Lung Disease 2005, 9: 1027-33. PMID: 16158896.Peer-Reviewed Original Research